Privileged delivery of polymer nanoparticles to the perinuclear region of live cells via a non-clathrin, non-degradative pathway

被引:216
作者
Lai, Samuel K.
Hida, Kaoru
Man, Stan T.
Chen, Clive
Machamer, Carolyn
Schroer, Trina A.
Hanes, Justin
机构
[1] Johns Hopkins Univ, Dept Chem & Biomol Engn, Baltimore, MD 21218 USA
[2] Johns Hopkins Univ, Dept Biomed Engn, Baltimore, MD 21218 USA
[3] Johns Hopkins Univ, Dept Biol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Inst NanobioTechnol, Baltimore, MD 21218 USA
[5] Johns Hopkins Univ, Sch Med, Sidney Kimmel Comprehens Care Ctr, Dept Oncol, Baltimore, MD 21231 USA
[6] Johns Hopkins Univ, Sch Med, Dept Cell Biol, Baltimore, MD 21231 USA
基金
加拿大自然科学与工程研究理事会;
关键词
intracellular delivery; trafficking; size; gene delivery; non-clathrin; non-caveolae;
D O I
10.1016/j.biomaterials.2007.02.021
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
The efficacy of many therapeutic molecules could be greatly enhanced by polymer-based nanoparticle systems capable of delivering them to the direct vicinity of the cell nucleus. However, degradation of the particles and encapsulated drugs within the enzyme-rich and low-pH environments of the endo/lysosomal pathway of cells has dramatically limited the efficacy of such systems. In this paper, we discovered that small polymeric particles (< 25 nm) but not larger particles (> 42 nm) enter live cells via a novel mechanism that leads to trafficking outside the endo/lysosomal pathway. Sub-25 nm particles rapidly transport to the perinuclear region of cells in vesicles that never acidify. The pathway is non-degradative, cholesterol independent, and non-clathrin and non-caveolae mediated. This privileged non-acidic pathway may be general since our results are surprisingly obtained with standard latex polymer beads without addition of ligands and may, therefore, provide a promising route for drug and gene delivery using biomaterial-based nanodevices. (C) 2007 Elsevier Ltd. All rights reserved.
引用
收藏
页码:2876 / 2884
页数:9
相关论文
共 54 条
[1]   Drug delivery systems: Entering the mainstream [J].
Allen, TM ;
Cullis, PR .
SCIENCE, 2004, 303 (5665) :1818-1822
[2]   Colon carcinoma cell glycolipids, integrins, and other glycoproteins mediate adhesion to HUVECs under flow [J].
Burdick, MM ;
McCaffery, JM ;
Kim, YS ;
Bochner, BS ;
Konstantopoulos, K .
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY, 2003, 284 (04) :C977-C987
[3]   Regulated portals of entry into the cell [J].
Conner, SD ;
Schmid, SL .
NATURE, 2003, 422 (6927) :37-44
[4]   Enhanced viscoelasticity of human cystic fibrotic sputum correlates with increasing microheterogeneity in particle transport [J].
Dawson, M ;
Wirtz, D ;
Hanes, J .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (50) :50393-50401
[5]  
DIWU Z, 1994, CYTOMETRY, P77
[6]   Molecular and enzymatic analyses of lysosomal acid lipase in cholesteryl ester storage disease [J].
Du, H ;
Sheriff, S ;
Bezerra, J ;
Leonova, T ;
Grabowski, GA .
MOLECULAR GENETICS AND METABOLISM, 1998, 64 (02) :126-134
[7]   The dawning era of polymer therapeutics [J].
Duncan, R .
NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (05) :347-360
[8]   DNase II: genes, enzymes and function [J].
Evans, CJ ;
Aguilera, RJ .
GENE, 2003, 322 :1-15
[9]   Plasmid size up to 20 kbp does not limit effective in vivo lung gene transfer using compacted DNA nanoparticles [J].
Fink, T. L. ;
Klepcyk, P. J. ;
Oette, S. M. ;
Gedeon, C. R. ;
Hyatt, S. L. ;
Kowalczyk, T. H. ;
Moen, R. C. ;
Cooper, M. J. .
GENE THERAPY, 2006, 13 (13) :1048-1051
[10]   Intracellular trafficking of hormone receptors [J].
Gáborik, Z ;
Hunyady, L .
TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2004, 15 (06) :286-293